Narayana Health has achieved HIMSS Analytics Maturity Assessment Model (AMAM) Stage 6 validation, becoming the first hospital in India and the Indian subcontinent to reach this level. It is also the second healthcare organisation in the Asia-Pacific region to achieve the milestone under the revised AMAM framework.
The HIMSS AMAM framework is a globally recognised benchmark that assesses how healthcare organisations use data, analytics and artificial intelligence to improve patient outcomes and operational efficiency. Stage 6 represents an advanced level of maturity, where predictive insights and near real-time intelligence support clinical and operational decision-making.
The achievement reflects Narayana Health’s decade-long focus on building a robust analytics ecosystem suited to the cost-sensitive realities of the Indian healthcare system.
Dr. Devi Shetty, Founder and Chairman of Narayana Health, said the self-pay nature of healthcare in India shaped the organisation’s approach to analytics from the beginning.
He said, “That reality pushed us to build operational and financial precision into every decision. We gave senior doctors visibility into metrics such as length of stay, procedure material costs, blood transfusions, re-exploration after surgery, mortality, morbidity and infection rates. Over time, this discipline has helped us steadily reduce mortality and morbidity, while improving productivity and keeping care within reach of our patients.”
Narayana Health has expanded from traditional reporting systems to an integrated analytics platform supporting clinical care, hospital operations and resource planning. Through Medha AI, the organisation uses analytics to improve patient flow, reduce waiting times and optimise workforce and bed utilisation.
Among its in-house innovations is Medha Scribe, an ambient documentation solution used in echocardiography workflows at the Narayana Institute of Cardiac Sciences. The platform captures findings during procedures and automatically generates reports, reducing turnaround time. Similar solutions are being introduced in radiology, outpatient services and operation theatres.
The organisation has also developed India-specific predictive models, including the NH Pre-Operative Risk Score for CABG surgeries and AI-assisted ECG models aimed at enabling earlier detection of cardiac abnormalities.
Commenting on the achievement, Dr. Emmanuel Rupert, Managing Director and Group CEO of Narayana Health, said, “Healthcare systems globally are being reshaped by the ability to use data meaningfully and responsibly. At Narayana Health, we recognised early on that analytics would be central to delivering better outcomes for patients at scale, while remaining grounded in the realities of Indian healthcare delivery. Achieving this level of validation reflects years of focused effort across teams, and reinforces our belief that world-class innovation can be built within India, for India.”
Mr. Vivek Rajagopal, Group Chief Analytics & AI Officer, added, “Our focus has been to make analytics practical, accessible and deeply embedded into everyday healthcare delivery rather than treating it as a standalone technology layer. We have built a unified ecosystem where clinical, operational and financial insights come together to help teams make faster and more consistent decisions. The HIMSS Stage 6 validation reflects not just technology maturity, but also the culture, governance and cross-functional collaboration required to operationalise analytics meaningfully at scale.”
By achieving HIMSS AMAM Stage 6 validation, Narayana Health has set a new benchmark for analytics-led healthcare in India. The milestone highlights the growing role of data and AI in delivering efficient, patient-centric and affordable healthcare solutions.
(Photo: AI generated)